CinRx Secures $73 Million to Foster Biotech Startups and Advance Obesity Treatments

- CinRx has secured $73 million in funding to support the creation of new biotech startups and advance obesity treatments.
- The company aims to spawn more biotech startups, focusing on innovative obesity drugs.
- This investment will help CinRx accelerate the development of its obesity treatment pipeline.
- CinRx's funding will also support the growth of its biotech startup portfolio, fostering innovation in the pharmaceutical industry.